Stock KH6 NEWAMSTERDAM PHARMA COMPANY N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions NewAmsterdam Pharma Company N.V. Deutsche Boerse AG

Equities

KH6

NL00150012L7

Market Closed - Deutsche Boerse AG
Other stock markets
 09:29:02 2024-07-12 am EDT 		5-day change 1st Jan Change
18.3 EUR +0.55% Intraday chart for NewAmsterdam Pharma Company N.V. +3.98% +86.73%
Jul. 08 NewAmsterdam Pharma Completes Enrollment for Phase 3 Trial of Potential Cardiovascular Disease Treatment MT
Jul. 08 NewAmsterdam Pharma Completes Enrollment in Pivotal Phase 3 TANDEM Clinical Trial Evaluating Fixed-Dose Combination of Obicetrapib plus Ezetimibe in Patients with HeFH and/or ASCVD or ASCVD Risk Factors CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. NAMS Stock
  4. KH6 Stock
  5. Revisions NewAmsterdam Pharma Company N.V.